Ethnic comparison in takotsubo syndrome: novel insights from the International Takotsubo Registry.
Broken heart syndrome
Ethnicity
Race
Takotsubo syndrome
Journal
Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
09
02
2021
accepted:
12
04
2021
pubmed:
21
5
2021
medline:
22
2
2022
entrez:
20
5
2021
Statut:
ppublish
Résumé
Ethnic disparities have been reported in cardiovascular disease. However, ethnic disparities in takotsubo syndrome (TTS) remain elusive. This study assessed differences in clinical characteristics between Japanese and European TTS patients and determined the impact of ethnicity on in-hospital outcomes. TTS patients in Japan were enrolled from 10 hospitals and TTS patients in Europe were enrolled from 32 hospitals participating in the International Takotsubo Registry. Clinical characteristics and in-hospital outcomes were compared between Japanese and European patients. A total of 503 Japanese and 1670 European patients were included. Japanese patients were older (72.6 ± 11.4 years vs. 68.0 ± 12.0 years; p < 0.001) and more likely to be male (18.5 vs. 8.4%; p < 0.001) than European TTS patients. Physical triggering factors were more common (45.5 vs. 32.0%; p < 0.001), and emotional triggers less common (17.5 vs. 31.5%; p < 0.001), in Japanese patients than in European patients. Japanese patients were more likely to experience cardiogenic shock during the acute phase (15.5 vs. 9.0%; p < 0.001) and had a higher in-hospital mortality (8.2 vs. 3.2%; p < 0.001). However, ethnicity itself did not appear to have an impact on in-hospital mortality. Machine learning approach revealed that the presence of physical stressors was the most important prognostic factor in both Japanese and European TTS patients. Differences in clinical characteristics and in-hospital outcomes between Japanese and European TTS patients exist. Ethnicity does not impact the outcome in TTS patients. The worse in-hospital outcome in Japanese patients, is mainly driven by the higher prevalence of physical triggers. URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT01947621.
Sections du résumé
BACKGROUND
BACKGROUND
Ethnic disparities have been reported in cardiovascular disease. However, ethnic disparities in takotsubo syndrome (TTS) remain elusive. This study assessed differences in clinical characteristics between Japanese and European TTS patients and determined the impact of ethnicity on in-hospital outcomes.
METHODS
METHODS
TTS patients in Japan were enrolled from 10 hospitals and TTS patients in Europe were enrolled from 32 hospitals participating in the International Takotsubo Registry. Clinical characteristics and in-hospital outcomes were compared between Japanese and European patients.
RESULTS
RESULTS
A total of 503 Japanese and 1670 European patients were included. Japanese patients were older (72.6 ± 11.4 years vs. 68.0 ± 12.0 years; p < 0.001) and more likely to be male (18.5 vs. 8.4%; p < 0.001) than European TTS patients. Physical triggering factors were more common (45.5 vs. 32.0%; p < 0.001), and emotional triggers less common (17.5 vs. 31.5%; p < 0.001), in Japanese patients than in European patients. Japanese patients were more likely to experience cardiogenic shock during the acute phase (15.5 vs. 9.0%; p < 0.001) and had a higher in-hospital mortality (8.2 vs. 3.2%; p < 0.001). However, ethnicity itself did not appear to have an impact on in-hospital mortality. Machine learning approach revealed that the presence of physical stressors was the most important prognostic factor in both Japanese and European TTS patients.
CONCLUSION
CONCLUSIONS
Differences in clinical characteristics and in-hospital outcomes between Japanese and European TTS patients exist. Ethnicity does not impact the outcome in TTS patients. The worse in-hospital outcome in Japanese patients, is mainly driven by the higher prevalence of physical triggers.
TRIAL REGISTRATION
BACKGROUND
URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT01947621.
Identifiants
pubmed: 34013386
doi: 10.1007/s00392-021-01857-4
pii: 10.1007/s00392-021-01857-4
pmc: PMC8816760
doi:
Banques de données
ClinicalTrials.gov
['NCT01947621']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
186-196Informations de copyright
© 2021. The Author(s).
Références
Int Arch Med. 2013 Apr 18;6(1):12
pubmed: 23597307
Eur Heart J. 2018 Jun 7;39(22):2047-2062
pubmed: 29850820
Cardiol Young. 2016 Feb;26(2):410-2
pubmed: 26279088
J Am Coll Cardiol. 1997 Jun;29(7):1607-14
pubmed: 9180126
Hypertens Res. 2014 Apr;37(4):253-390
pubmed: 24705419
Heart. 1997 Nov;78(5):509-11
pubmed: 9415014
N Engl J Med. 2015 Sep 3;373(10):929-38
pubmed: 26332547
Am J Emerg Med. 2013 Nov;31(11):1627.e1-4
pubmed: 23891597
J Cardiol. 1991;21(2):203-14
pubmed: 1841907
Heart. 2017 Sep;103(18):1461-1469
pubmed: 28839096
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Am Heart J. 2012 Aug;164(2):215-21
pubmed: 22877807
Circ J. 2014;78(9):2119-28
pubmed: 25099475
Eur Heart J. 2018 Jun 7;39(22):2032-2046
pubmed: 29850871
Heart. 2016 Jul 1;102(13):1029-35
pubmed: 26879240
Am J Epidemiol. 2008 Feb 1;167(3):362-8
pubmed: 17982157
Int J Cardiovasc Imaging. 2014 Dec;30(8):1417-8
pubmed: 24929873
J Am Coll Cardiol. 2018 Aug 21;72(8):874-882
pubmed: 30115226
Int J Cardiol. 2015 Apr 15;185:282-9
pubmed: 25818540
S Afr Med J. 2015 Apr 10;105(5):422
pubmed: 26242680
Chest. 1998 Jul;114(1):98-105
pubmed: 9674454
J Am Coll Cardiol. 2016 Apr 26;67(16):1931-6
pubmed: 27102508
Intern Med. 2012;51(3):257-62
pubmed: 22293799
Curr Cardiovasc Risk Rep. 2015 Apr;9(4):
pubmed: 26401192
J Cardiol. 2017 Dec;70(6):615-619
pubmed: 28522138
Cardiol J. 2016;23(3):352-4
pubmed: 27377800
J Cardiol. 2014 Apr;63(4):269-73
pubmed: 24139869
Curr Cardiol Rev. 2015;11(3):238-45
pubmed: 25418513